Lv1
50 积分 2021-10-24 加入
Claudin 18.2 as a novel therapeutic target
1天前
已完结
Targeting CLDN18.2 in cancers of the gastrointestinal tract: New drugs and new indications
1天前
已完结
Adjuvant gefitinib versus cisplatin/vinorelbine in Japanese patients with completely resected, EGFR-mutated, stage II-III non-small cell lung cancer (IMPACT, WJOG6410L): A randomized phase 3 trial
7个月前
已关闭
Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials
7个月前
已完结
Discovery of the RANKL/RANK/OPG system
8个月前
已完结
Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study
8个月前
已完结
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass
8个月前
已完结
Bone-Muscle Mutual Interactions
8个月前
已完结
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation
8个月前
已完结
Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus
8个月前
已完结
皖公网安备34019202002308
